The Dropout cover image

The Dropout

The Investors

Nov 2, 2021
41:50

Podcast summary created with Snipd AI

Quick takeaways

  • Investors were swayed by Theranos' promises of groundbreaking technology and comprehensive tests requiring minimal blood, despite inconsistencies and lack of thorough scrutiny.
  • Investors like Lisa Peterson trusted Theranos based on manipulated documents and endorsements, leading to questions about the legitimacy of the company's claims.

Deep dives

Investing with Theranos and Elizabeth Holmes' Bold Claims

Investors like Bryan Talbert from the Hall Group were drawn to Theranos by the promise of revolutionary technology that required just a drop of blood for comprehensive tests. Talbert believed in Holmes' claims that the technology had advanced significantly, allowing for a wide range of laboratory tests to be conducted. Despite the lack of due diligence, he trusted Theranos' ability to deliver on its promises, unaware of discrepancies like the use of venous draws instead of finger sticks.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode